Trexquant Investment’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$828K Sell
9,609
-57,626
-86% -$5.17M 0.01% 1292
2025
Q4
$5.87M Buy
+67,235
New +$5.1M 0.05% 518
2025
Q2
Sell
-62,817
Closed -$4.6M 1657
2025
Q1
$4.6M Sell
62,817
-79,504
-56% -$6.57M 0.05% 536
2024
Q4
$11.8M Buy
+142,321
New +$11.2M 0.14% 220
2023
Q3
Sell
-60,916
Closed -$3.63M 1588
2023
Q2
$3.63M Buy
60,916
+37,911
+165% +$2.16M 0.1% 293
2023
Q1
$1.3M Buy
+23,005
New +$1.48M 0.04% 622
2022
Q4
Sell
-13,743
Closed -$819K 1501
2022
Q3
$819K Buy
13,743
+9,560
+229% +$576K 0.03% 607
2022
Q2
$235K Buy
+4,183
New +$275K 0.01% 1263
2022
Q1
Sell
-3,044
Closed -$220K 1492
2021
Q4
$220K Sell
3,044
-964
-24% -$70K 0.01% 1102
2021
Q3
$307K Buy
+4,008
New +$322K 0.02% 726
2021
Q2
Sell
-4,700
Closed -$290K 1237
2021
Q1
$290K Buy
+4,700
New +$298K 0.03% 770
2020
Q4
Sell
-7,579
Closed -$375K 1194
2020
Q3
$375K Sell
7,579
-15,384
-67% -$793K 0.02% 826
2020
Q2
$1.1M Buy
22,963
+783
+4% +$37.8K 0.08% 371
2020
Q1
$943K Buy
22,180
+10,255
+86% +$507K 0.07% 433
2019
Q4
$702K Buy
+11,925
New +$647K 0.04% 461
2019
Q3
Sell
-10,578
Closed -$447K 951
2019
Q2
$447K Buy
10,578
+1,602
+18% +$69.6K 0.04% 494
2019
Q1
$444K Sell
8,976
-20,879
-70% -$944K 0.03% 611
2018
Q4
$1.29M Buy
29,855
+20,746
+228% +$1.04M 0.08% 362
2018
Q3
$517K Buy
+9,109
New +$479K 0.04% 525
2018
Q2
Sell
-9,232
Closed -$460K 1009
2018
Q1
$460K Buy
+9,232
New +$434K 0.03% 669
2017
Q2
Sell
-27,700
Closed -$820K 918
2017
Q1
$820K Buy
+27,700
New +$756K 0.11% 330
2016
Q2
Sell
-53,421
Closed -$1.27M 949
2016
Q1
$1.27M Buy
53,421
+33,021
+162% +$807K 0.15% 215
2015
Q4
$568K Buy
+20,400
New +$512K 0.05% 631
2015
Q2
Sell
-70,400
Closed -$1.78M 1070
2015
Q1
$1.78M Buy
70,400
+56,815
+418% +$1.38M 0.18% 142
2014
Q4
$322K Buy
+13,585
New +$301K 0.06% 666

Other funds holding GMED

Trexquant Investment's GMED Position: Q1 2026 in Review

Trexquant Investment reduced its Globus Medical (GMED) stake by 86% in Q1 2026, selling an estimated $5.17M and leaving 9,609 shares worth $828K. The position accounts for 0.01% of the portfolio, ranked #1292.

Trexquant Investment first reported a position in GMED in Q4 2014 and has held it in 25 quarters since. The position peaked at $11.8M in Q4 2024. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Trexquant Investment held 9,609 shares of Globus Medical worth $828K as of Q1 2026.
  • Trexquant Investment sold 57,626 Globus Medical shares in Q1 2026, an estimated $5.17M.
  • Globus Medical made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1292 holding.
  • Trexquant Investment first reported a position in Globus Medical in Q4 2014 and has held it in 25 quarters since.
  • Trexquant Investment's Globus Medical position peaked at $11.8M in Q4 2024.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.